A novel ErbB2 epitope targeted by human antitumor immunoagents
about
Trastuzumab Induces an Immediate, Transient Volume Increase in Humans: A Randomised Placebo-Controlled TrialA novel fully human antitumor immunoRNase resistant to the RNase inhibitorEffects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells.Effects of a human compact anti-ErbB2 antibody on gastric cancer.Mechanisms of cardiotoxicity associated with ErbB2 inhibitors.Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors.
P2860
A novel ErbB2 epitope targeted by human antitumor immunoagents
description
im März 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2011
@uk
name
A novel ErbB2 epitope targeted by human antitumor immunoagents
@en
A novel ErbB2 epitope targeted by human antitumor immunoagents
@nl
type
label
A novel ErbB2 epitope targeted by human antitumor immunoagents
@en
A novel ErbB2 epitope targeted by human antitumor immunoagents
@nl
prefLabel
A novel ErbB2 epitope targeted by human antitumor immunoagents
@en
A novel ErbB2 epitope targeted by human antitumor immunoagents
@nl
P2093
P2860
P50
P1433
P1476
A novel ErbB2 epitope targeted by human antitumor immunoagents
@en
P2093
Carmine Fedele
Filomena Sica
Fulvia Troise
Giuseppe D'Alessio
P2860
P304
P356
10.1111/J.1742-4658.2011.08041.X
P407
P577
2011-03-01T00:00:00Z